Cargando…
Sovateltide (IRL-1620) activates neuronal differentiation and prevents mitochondrial dysfunction in adult mammalian brains following stroke
The development of effective drugs for stroke is urgently required as it is the 2nd largest killer in the world and its incidence is likely to increase in the future. We have demonstrated cerebral endothelin B receptors (ETBR) as a potential target to treat acute cerebral ischemic stroke. However, t...
Autores principales: | Ranjan, Amaresh K., Briyal, Seema, Gulati, Anil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391684/ https://www.ncbi.nlm.nih.gov/pubmed/32728189 http://dx.doi.org/10.1038/s41598-020-69673-w |
Ejemplares similares
-
Safety and Efficacy of Sovateltide (IRL-1620) in a Multicenter Randomized Controlled Clinical Trial in Patients with Acute Cerebral Ischemic Stroke
por: Gulati, Anil, et al.
Publicado: (2021) -
Anti-apoptotic activity of ET(B) receptor agonist, IRL-1620, protects neural cells in rats with cerebral ischemia
por: Briyal, Seema, et al.
Publicado: (2019) -
Author Correction: Anti-apoptotic activity of ET(B) receptor agonist, IRL-1620, protects neural cells in rats with cerebral ischemia
por: Briyal, Seema, et al.
Publicado: (2020) -
Attenuation of opioid tolerance by ET(B) receptor agonist, IRL-1620, is independent of an accompanied decrease in nerve growth factor in mice
por: Gulati, Shruti, et al.
Publicado: (2017) -
Sovateltide Mediated Endothelin B Receptors Agonism and Curbing Neurological Disorders
por: Ranjan, Amaresh K., et al.
Publicado: (2022)